ArticleScientific reports2024
Designing a novel fractional order mathematical model for COVID-19 incorporating lockdown measures.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Resurgence in focus: Covid-19 dynamics and optimal control frameworks.Global epidemiology · 2025Article
- Who continued travelling by bus in different periods of COVID-19? A data-driven analysis from Shanghai, China.PloS one · 2025Article
- Fractional order system identification using a joint multi-innovation fractional gradient descent algorithm.Scientific reports · 2024Article
- A data-driven analysis on the mediation effect of compartment models between control measures and COVID-19 epidemics.Heliyon · 2024Article
- An innovative fractional-order evolutionary game theoretical study of personal protection, quarantine, and isolation policies for combating epidemic diseases.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research focuses on the design of a novel fractional model for simulating the ongoing spread of the coronavirus (COVID-19). The model is composed of multiple categories named susceptible [Formula: see text], infected [Formula: see text], treated [Formula: see text], and recovered [Formula: see text] with the susceptible category further divided into two subcategories [Formula: see text] and [Formula: see text]. In light of the need for restrictive measures such as mandatory masks and social distancing to control the virus, the study of the dynamics and spread of the virus is an important topic. In addition, we investigate the positivity of the solution and its boundedness to ensure positive results. Furthermore, equilibrium points for the system are determined, and a stability analysis is conducted. Additionally, this study employs the analytical technique of the Laplace Adomian decomposition method (LADM) to simulate the different compartments of the model, taking into account various scenarios. The Laplace transform is used to convert the nonlinear resulting equations into an equivalent linear form, and the Adomian polynomials are utilized to treat the nonlinear terms. Solving this set of equations yields the solution for the state variables. To further assess the dynamics of the model, numerical simulations are conducted and compared with the results from LADM. Additionally, a comparison with real data from Italy is demonstrated, which shows a perfect agreement between the obtained data using the numerical and Laplace Adomian techniques. The graphical simulation is employed to investigate the effect of fractional-order terms, and an analysis of parameters is done to observe how quickly stabilization can be achieved with or without confinement rules. It is demonstrated that if no confinement rules are applied, it will take longer for stabilization after more people have been affected; however, if strict measures and a low contact rate are implemented, stabilization can be reached sooner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.